>
Switch to:

Ionis Pharmaceuticals Earnings per Share (Diluted)

: $-3.24 (TTM As of Dec. 2020)
View and export this data going back to 1991. Start your Free Trial

Ionis Pharmaceuticals's Earnings per Share (Diluted) for the three months ended in Dec. 2020 was $-2.44. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was $-3.24.

Ionis Pharmaceuticals's EPS (Basic) for the three months ended in Dec. 2020 was $-2.44. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2020 was $-3.24.

Ionis Pharmaceuticals's EPS without NRI for the three months ended in Dec. 2020 was $-2.44. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2020 was $-3.24.

During the past 12 months, Ionis Pharmaceuticals's average EPS without NRIGrowth Rate was -255.30% per year.

During the past 13 years, Ionis Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 71.20% per year. The lowest was -117.80% per year. And the median was -2.75% per year.

Ionis Pharmaceuticals Earnings per Share (Diluted) Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Ionis Pharmaceuticals Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Earnings per Share (Diluted) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.50 0.15 2.07 2.08 -3.23

Ionis Pharmaceuticals Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Earnings per Share (Diluted) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 -0.35 -0.23 -0.22 -2.44
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Ionis Pharmaceuticals Earnings per Share (Diluted) Distribution

* The bar in red indicates where Ionis Pharmaceuticals's Earnings per Share (Diluted) falls into.


Ionis Pharmaceuticals Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Ionis Pharmaceuticals's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2020 is calculated as

Diluted Earnings Per Share (A: Dec. 2020 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-451.286-0)/139.612
=-3.23

Ionis Pharmaceuticals's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2020 is calculated as

Diluted Earnings Per Share (Q: Dec. 2020 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-340.271-0)/139.957
=-2.43

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2020 was -0.35 (Mar. 2020 ) + -0.23 (Jun. 2020 ) + -0.22 (Sep. 2020 ) + -2.44 (Dec. 2020 ) = $-3.24

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Ionis Pharmaceuticals  (NAS:IONS) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Ionis Pharmaceuticals Earnings per Share (Diluted) Related Terms

Ionis Pharmaceuticals Earnings per Share (Diluted) Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)